[1] |
Rubin CD. Age-related osteoporosis[J]. Am J Med Sci, 1991,301(4):281-298. DOI: 10.1097/00000441-199104000-00012.
|
[2] |
Heaney RP. Age-related osteoporosis in Chinese women[J]. Am J Clin Nutr, 1999,69(6):1291-1292. DOI: 10.1093/ajcn.
|
[3] |
Maclaughlin EJ, Sleeper RB, McNatty D, et al. Management of age-related osteoporosis and prevention of associated fractures[J]. Ther Clin Risk Manag, 2006,2(3):281-295. DOI: 10.2147/tcrm.2006.2.3.281.
|
[4] |
丁超. 老年性骨质疏松症相关问题研究进展[J]. 中国骨质疏松杂志, 2016,22(3):372-375. DOI:10.3969/j.issn.1006-7108.2016.03.025.
|
[5] |
Compston JE, McClung MR, Leslie WD. Osteoporosis[J]. Lancet, 2019,393(10169):364-376. DOI: 10.1016/S0140-6736(18)32112-3.
|
[6] |
Wang Y, Wang B, Yang X. The Study of Cellular Mechanism of Triptolide in the Treatment of Cancer, Bone Loss and Cardiovascular Disease and Triptolide's Toxicity[J]. Curr Stem Cell Res Ther, 2020,15(1):18-23. DOI: 10.2174/1574888X14666190301155810.
|
[7] |
Park B. Triptolide, a diterpene, inhibits osteoclastogenesis, induced by RANKL signaling and human cancer cells[J]. Biochimie, 2014,105:129-136. DOI: 10.1016/j.biochi.2014.07.003.
|
[8] |
Cui J, Li X, Wang S, et al. Triptolide prevents bone loss via suppressing osteoclastogenesis through inhibiting PI3K-AKT-NFATc1 pathway[J]. J Cell Mol Med, 2020,24(11):6149-6161. DOI: 10.1111/jcmm.15229.
|
[9] |
彭坤. 骨质疏松性骨折治疗效果的改善:研究现状及策略分析[J]. 中国组织工程研究, 2022, 26(6):1027-1032. DOI: 10.12307/2022.189.
|
[10] |
张文静. 骨质疏松治疗的相关研究进展[J]. 中国老年保健医学, 2020,18(04):101-102. DOI: 10.3969/j.issn.1672-2671.2020.04.033.
|
[11] |
井莹莹, 王一力, 苏佳灿. 骨微环境对骨质疏松性骨折骨愈合的作用及其机制[J]. 中华创伤杂志, 2021, 37(8):683-687. DOI: 10.3760/cma.j.cn501098-20210331-00215.
|
[12] |
邓飞飞, 宋强, 张成涛, 等. 骨质疏松相关分子病因及治疗研究进展[J]. 中华实验外科杂志, 2021,38(6):1186-1188. DOI: 10.3760/cma.j.cn421213-20201023-01379.
|
[13] |
林若慧, 李生强, 陈娟, 等. 长链非编码RNA的中医药治疗骨质疏松症研究进展[J]. 中国骨质疏松杂志, 2021,27(9):1395-1399. DOI: 10.3969/j.issn.1006-7108.2021.09.029.
|
[14] |
Ogbechi J, Clanchy FI, Huang YS, et al. IDO activation, inflammation and musculoskeletal disease[J]. Exp Gerontol, 2020,131:110820. DOI: 10.1016/j.exger.2019.110820.
|
[15] |
Lacativa PG, Farias ML. Osteoporosis and inflammation[J]. Arq Bras Endocrinol Metabol, 2010,54(2):123-132. DOI: 10.1590/s0004-27302010000200007.
|
[16] |
Fang H, Zhang H, Wang Z, et al. Systemic immune-inflammation index acts as a novel diagnostic biomarker for postmenopausal osteoporosis and could predict the risk of osteoporotic fracture[J]. J Clin Lab Anal, 2020,34(1):e23016. DOI: 10.1002/jcla.23016.
|
[17] |
李晶芳, 韩蕊, 殷宏庆, 等. 雷公藤治疗肾脏疾病及其毒副作用的研究进展[J]. 中国实验方剂学杂志, 网络首发时间:2021-05-20. DOI: 10.13422/j.cnki.syfjx.20211305.
|
[18] |
Kitzen JJ, de Jonge MJ, Lamers CH, et al. Phase I dose-escalation study of F60008, a novel apoptosis inducer, in patients with advanced solid tumours[J]. Eur J Cancer, 2009,45(10):1764-1772. DOI: 10.1016/j.ejca.2009.01.026.
|
[19] |
Yuan Z, Zhang H, Hasnat M, et al. A new perspective of triptolide-associated hepatotoxicity: Liver hypersensitivity upon LPS stimulation[J]. Toxicology, 2019,414:45-56. DOI: 10.1016/j.tox.2019.01.005.
|